Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil-helix-coiled-coil-helix domain-containing protein 6 (CHCHD6) is a mitochondrial protein predominantly localized to the inner mitochondrial membrane as a core component of the MICOS (mitochondrial contact site and cristae organizing system) complex[1][3][5]. It is essential for the maintenance of cristae morphology and mitochondrial inner membrane architecture, directly interacting with other MICOS proteins like mitofilin and CHCHD3[1][3]. Disruption or loss of CHCHD6 impairs mitochondrial structure, leads to bioenergetic failure, and increases susceptibility to genotoxic stress, thereby reducing cell growth and ATP production[1][2]. In Alzheimer’s disease models and human tissues, CHCHD6 is selectively reduced, linking it to amyloid processing, mitochondrial dysfunction, and neurodegeneration, suggesting a potential therapeutic target for AD and possibly cancer[1][2][5]. It does not belong to classical drug target categories like receptors or enzymes but is considered a target due to its role in disease-related cellular processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil-helix-coiled-coil-helix domain-containing protein 6 (CHCHD6).